Month December 2024

Cytokinetics inventory rises on Sanofi’s rights acquisition

Investing.com — Shares of Cytokinetics (NASDAQ:CYTK), Included (NASDAQ:CYTK) climbed 4.8% after the corporate introduced that Sanofi (NASDAQ:SNY) will purchase unique rights to develop and commercialize aficamten in Better China, a transfer that underscores the drug’s potential in treating hypertrophic cardiomyopathy…